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Abstract 
The purpose of this work was to study the influence of “Bendamin” on the morphological and biochemical indices 
of rat blood in experimental modeling of heart failure. The investigation were performed on white sexually mature 
young  male-rats of Wistar line  weighing 180–200 g, kept at the standard ration of the institute vivarium of the 
State Research Institute of Veterinary Preparations and Fodder Additives. To create a model of doxorubicin-
induced cardiomyopathy, 24 male rats were selected. Animals were divided into 3 groups of 6 animals in each: 
control group – intact animals; experimental group E1, in which animals were modeled doxorubicin-induced 
cardiomyopathy by intraperitoneal injected of doxorubicin at a dose of 2.5 mg/kg 3 times a week for two weeks; 
experimental group E2, in which animals, after injection of doxorubicin, the preparation “Bendamin” was injected 
in the dose 20 mg/kg intragastrically. For experimental modeling of heart a decrease in the number of red blood 
cells was found in the blood of rats of the first experimental group by 34.7 % and hemoglobin level – by 24.2 %, 
with a simultaneous increase in the average hemoglobin content in one erythrocyte by 16.2 %. Doxorubicin-
induced cardiomyopathy in rats of the first experimental group was accompanied by a decrease in leukocyte count 
by 22.2 %, an increase in uric acid level by almost in 2 times, creatinine by 11.4 %, cholesterol by 61.1 %. In the 
research of the protein synthesizing function of the liver of rats in experimental modeling of heart failure, a de-
crease in total protein by 9.6 % was found. These changes were accompanied by a slight decrease in albumin 
levels and a slight increase in globulin levels. By intoxication with doxorubicin, rats of the first experimental 
group showed a violation of the functional state of the liver, indicating an increase in the activity of aminotransfer-
ases in their blood, namely: AlAT by 34.2 %, AsAT – by 21.7 %, accordingly. Positive action of cardio prepara-
tion “Bendamin” on rats organism under conditions of creation of a model of doxorubicin-induced cardiomyopa-
thy was installed, manifested by the normalization of hematological and biochemical parameters, functional status 
and protein synthesis of the liver. 
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1. Introduction
Cardiology is one of the directions of veterinary medi-
cine which is most intensively developing. Annually, a large 
number of new investigations are conducted in the world, 
based on the results of which refine the views on the treat-
ment of cardiovascular diseases (Varkholiak & Gutyj, 
2018). Recently, our ideas about the pathogenetic mecha-
nisms of heart failure have changed significantly, and new 
approaches to its therapy are being developed (Tjostheim et 
al., 2019; Oldach et al., 2019). 
Cardiac and vascular pathologies in dogs and cats are ex-
tremely diverse and fairly common in the daily practice of a 
veterinarian in Ukraine and beyond. According to the classi-
fication of Professor G. V. Domrachev, in domestic animals, 
cardiovascular pathology is divided into diseases of the 
myocardium, pericardium, endocardium and diseases of the 
blood vessels. There is a close relationship between the 
above pathologies, age and animal breeds (Undhad et al., 
2012; Varkholiak, 2016; Zhulikova, 2016; Yata et al., 2019). 
According to foreign authors, cardiovascular pathology 
is about 10.0 % of all pathologies of the internal organs. 
During 2014–2018, pets with the following pathologies 
were coming in at the “DoctorVET” in Animal Health Cen-
ter of Lviv: cardiomyopathy (dilatation, hypertrophic, ar-
rhythmogenic), MK endocardiosis, isolated cases of birth 
defects, and also pericarditis. 
In recent years, several significant investigations have 
been conducted in the field of treatment of heart failure, new 
diagnostic techniques were introduced, the genetic features 
of particular pathologies were identified, and new medicines 
appeared, such as pimobendan, polyunsaturated fatty acids, 
sildenafil, levosimendan, torasemide, nebivolol, lisinopril, 
clopidogrel, and some others. However, data on the use of 
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new  therapeutic  means  in  cardiovascular  pathology  is  not  
enough (Trofimjak & Slivinska, 2016; Varkholiak & Gutyj, 
2019; Varcholyak & Gutyi, 2019). 
Thus,  there  is  a  reasonable  need  to  develop,  conduct  
comprehensive  investigations  of  the  mechanisms  of  action  
of  the  medicines,  its  interaction  with  other  preparations,  
clinical  efficiency of treatment and safety of  animals in the 
development of cardiovascular pathology. 
The purpose of the work is to investigate the influence of 
cardio  preparation  “Bendamin”  on  the  morphological  and  
biochemical  indices  of  rat  blood  in  experimental  modeling  
of heart failure. 
2. Materials and methods
The investigations were  performed  on  white  sexually  
mature  young  rats-males  of  the  Wistar  line  weighing  180–
200 g, which were kept on a standard ration of the institute 
vivarium of the State Research Institute of Veterinary Prepa-
rations and Feed Additives. Throughout the experiment, rats 
were  kept  in  a  balanced  ration  containing  all  the  necessary  
components, and animals were provided with drinking water 
without restrictions from 0.2 liter glass bowls. 
The  experimental  investigations  were  conducted  in  ac-
cordance  with  the  requirements  of  the  biological-biological 
experiment  for  the  selection  of  analogues,  setting  control,  
compliance  with  the  same feeding  conditions  and  retention  
during the experiment and the results. 
To create a model of doxorubicin-induced cardiomyopa-
thy,  24 male  rats  were  selected.  Animals  were  divided into  
3 groups  of  6  animals  in  each:  control  group  – intact  ani-
mals;  experimental  group  E1,  in  which  animals  were  mod-
eled doxorubicin-induced cardiomyopathy by intraperitoneal 
introduction of doxorubicin at a dose of 2.5 mg/kg 3 times a 
week  for  two  weeks;  experimental  group  E2,  in  which  ani-
mals  were  injected  intragastrically  with  “Bendamin”  at  a  
dose of 20 mg/kg. 
Morphological  and  biochemical  indices  of  blood  were  
investigated by the method (Vlizlo et al., 2012). 
All animal manipulations were carried out in accordance 
with  the  European  Convention  for  the  Protection  of  Verte-
brate Animals, which is used for experimental and scientific 
purposes (Strasbourg, 1986). 
Analysis of the research results was performed using the 
Statistica  6.0  software  package.  The  probability  of  differ-
ences  was  evaluated  by  Student's  t-test.  The  results  were  
considered probable at P ≤ 0.05. 
3. Results and discussion
In experimental modeling of heart failure by intraperito-
neal injection of doxorubicin at a dose of 2.5 mg/kg 3 times 
a  week  for  two  weeks,  was  found  reducing the  number  of  
erythrocytes  in  the  blood  of  rats  of  the  first  experimental  
group by 34.7 % and hemoglobin level – by 24.2 %, with a 
simultaneous increase in the average hemoglobin content in 
one erythrocyte by 16.2 % (Table. 1). These changes may be 
related  to  the negative action  of  oxidative  stress  on cardio-
myocytes. 
In the search of the above mentioned indices in the blood 
of  the  experimental  group  E2 an  increase  in  the  number  of  
erythrocytes and hemoglobin level compared with sick ani-
mals  was  observed.  It  should  be  noted  that  the  number  of  
erythrocytes in the blood of rats treated with the preparation 
“Bendamin” ranged from 7.14 ± 0.547 T/l, whereas in rats  
of  the  first  experimental  group  this  indicator  was  
4.94 ± 0.125 T/l. In the research of hemoglobin in the blood 
of rats in the experimental groups, their increase is found in 
the second experimental group of rats compared to the first 
experimental  group,  however,  when  compared  with  the  
control group, this indicator was lower by 5.7 %, respective-
ly. 
The average  hemoglobin  content  in  one  erythrocyte  was  
higher in the first experimental group, where it was respective-
ly  17.71 ± 1.10  pg,  slightly  lower  was  in  the  second  experi-
mental group. 
Doxorubicin-induced cardiomyopathy in rats of the first 
experimental group was accompanied by a decrease in  leu-
kocyte  number  by  22.2 %,  which  may  be  related  to  a  de-
crease in immunity and inhibition of leukocyte formation in 
the bone marrow against the background of oxidative stress 
caused by the injection of doxorubicin. 
When using the preparation “Bendamin” to experimental 
rats under the conditions of experimental modeling of heart 
failure  was  found  an  increase  of  their  number  to  
6.58 ± 0.55 G/l, which is 26.3 % higher than the indices of 
the first experimental group. 
In  order  to  evaluate  the  influence  of  preparation  
“Bendamin”  in  simulated  doxorubicin-induced 
cardiomyopathy,  on  kidney  condition  was  determined  by  
such  indicators  as uric  acid  and  creatinine  levels.  It  was  
Installed, that in the first experimental group of rats uric acid 
levels were increased almost in 2-times,  whereas creatinine 
levels  were  increased  by  11.4  %.  The  lowest  level  of  uric  
acid was in the experimental group E2, which along with the 
intoxication  of  doxorubicin  were  used  the  preparation  
“Bendamin”. Similar  changes  are  observed  in  the  research  
of creatinine level, which in the experimental group E2 was 
fluctuated  respectively  within  50.4  ±  1.54  μmol/l,  whereas  
in  the  control  group  of  rats  this  indicator  was  
49.0  ±  1.07  μmol/l.  These  changes  in  the  blood  of  the  
second  experimental  group  indicate  a  partial  normalization  
of renal function. 
We  found  that  in  modeling  heart  failure  in  the  experi-
mental animals of the first experimental group there was an 
increase  in  cholesterol  level  by  61.1 %  compared  with  the  
control group. It should be noted that when using the prepa-
ration “Bendamin” cholesterol  level  was  decreased  by  
36.3 % and reached physiological values. 
Reorientation  of  oxidative  metabolism  in  the  
myocardium  to  the  anaerobic  pathway  as  a  result  of  rats  
intoxication  with  doxorubicin  and  damage  to  their  heart  
muscle  was  reflected  by  a  59 %  increase  in  the  creatine  
phosphokinase  MB  activity  in  the  rats  serum  of  the  first  
experimental group compared with indicators taken from the 
control group of rats. This enzyme is a specific and sensitive 
marker of myocardial damage. 
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Table 1 
Morphological and biochemical indices of blood of rats in experimental modeling of heart failure and action of the preparation 
“Bendamin” (M ± m, n = 6) 
Indicators Groups of animals Control Experimental 1 Experimental 2 
Erythrocytes, T/l  7.57 ± 0.349  4.94 ± 0.125*  7.14 ± 0.547 
Hemoglobin, g/l 115.4 ± 2.9   87.5 ± 2.0* 110.6 ± 3.2 
The average hemoglobin content in one erythrocyte, pg 15.24 ± 1.14 17.71 ± 1.10* 15.49 ± 1.15 
Leukocytes, G/l  6.70 ± 0.62  5.21 ± 0.75*  6.58 ± 0.55 
Creatinine, μmol/l  49.0 ± 1.07  54.6 ± 2.27*  50.4 ± 1.54 
Cholesterol, mmol/l  1.90 ± 0.072  3.06 ± 0.057*  1.95 ± 0.072 
Uric acid, μmol/l  83.4 ± 3.60 164.2 ± 4.11*  91.3 ± 5.35 
LDH, mmk/l  1.93 ± 0.20   1.85 ± 0.15  2.10 ± 0.30 
Creatine phosphokinase MB, in units/l  78 ± 3.1    124 ± 4.3*  105 ± 3.9 
The injection of the cardio preparation to the experi-
mental rats contributed to a slight decrease in creatine phos-
phokinase MB activity by 15.3 % compared with the first 
experimental group. 
One of the major enzymes involved in glycolysis reac-
tions is lactate dehydrogenase. Based on the conducted re-
search, it was found that LDH activity in the blood of rats of 
the first experimental group decreased by 4 % due to doxo-
rubicin intoxication. When using the “Bendamin” cardio 
preparation, to rats of the E2 experimental group were found 
the increase of this enzyme compared to the control and the 
first experimental group, here, accordingly, LDH activity 
ranged from 2.10 ± 0.30 mmk/l. 
In the research of the protein synthesizing function of rat 
liver in experimental modeling of heart failure and the 
action of the “Bendamin” cardio preparation reduced the 
total protein in the first experimental group by 9.6 %, of the 
second experimental group – by 2.3 % compared with the 
control group (Table 2). 
Table 2 
Protein synthesizing function of rat liver in experimental modeling of heart failure and action of “Bendamin” preparation 
(M ± m, n = 6) 
Indices Groups of animals Control Experimental 1 Experimental 2 
Total protein, g/l 62.31 ± 3.12 56.32 ± 3.57* 60.84 ± 2.78 
Albumin, g/l 24.12 ± 2.18 17.57 ± 3.34* 22.67 ± 2.45 
Globulins, g/l 38.19 ± 3.41 38.75 ± 4.10 38.17 ± 3.11 
These changes were accompanied by a slight decrease in 
albumin levels and a slight increase in globulin levels, the 
level of albumins and globulins was thus set at 
17.57 ± 3.34 and 38.75 ± 4.10 g/l in the first experimental 
group versus 24.12 ± 2.18 and 38.19 ± 3.41 in the control 
group of rats. 
By intoxication with doxorubicin in rats of the first ex-
perimental group was found violations of the functional 
state of the liver which is indicated by increased activity of 
aminotransferases in their blood, namely: AlAT by 34.2 %, 
AsAT – by 21.7 %, respectively (Table 3). 
Table 3 
Functional state of rat liver in experimental modeling of heart failure and action of the preparation “Bendamin” (M ± m, n = 6) 
Indices Groups of animals Control Experimental 1 Experimental 2 
AlAT, un/l 38.47 ± 2.10 51.62 ± 3.57* 38.50 ± 2.10 
AlAT, un/l 188.5 ± 15.86 229.4 ± 10.30* 189.2 ± 11.25 
The use of the preparation “Bendamin” in experimental 
rats under experimental modeling of heart failure, was set up 
a decrease in the activity of aminotransferases in serum of 
experimental group E2. Thus, the activity of AlAT and 
AsAT in the serum of the second experimental group was 
decreased by 25.4 and 17.5 %, respectively, compared to the 
intoxicated rats, who were not given a cardiac preparation. 
4. Conclusions
Based on our research, positive action of “Bendamin” 
cardio preparation on rats organism was set up under the 
conditions of creation of a doxorubicin-induced cardiomyo-
pathy model, that appears itself by the normalization of 
hematological and biochemical indices, functional status and 
protein synthesis function of the liver. 
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